powerwalker, I still see his name in the Management section, so not sure where you are looking. Making multiple presentations might aloss indicate something more impending coming out of Anavex.
Our Team Management Christopher U. Missling, PhD, MS, MBA Terrie Kellmeyer, PhD Daniel Klamer, PhD, MS, MBA Walter E Kaufmann, MD Adebayo Laniyonu, PhD Juan Carlos Lopez-Talavera, MD, PhD Kun Jin, PhD Jeffrey Edwards, PhD Edward Hammond, MD, PhD, MPH David Goldberger, RPh, MLS
Kaufmann did fail to fulfil the Anavex strategic goal of rare disease approval and revenue as the top priority, instead of AD. With the Excellence fail, Anavex is now back to hoping for an AD approval before one in a rare disease.
Could be lining up to let Kaufmann go...but I still see Kaufmann on Anavex.com as part of the Management Team.